1. Home
  2. LEE vs ITRM Comparison

LEE vs ITRM Comparison

Compare LEE & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • ITRM
  • Stock Information
  • Founded
  • LEE 1890
  • ITRM 2015
  • Country
  • LEE United States
  • ITRM Ireland
  • Employees
  • LEE N/A
  • ITRM N/A
  • Industry
  • LEE Newspapers/Magazines
  • ITRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEE Consumer Discretionary
  • ITRM Health Care
  • Exchange
  • LEE Nasdaq
  • ITRM Nasdaq
  • Market Cap
  • LEE 33.8M
  • ITRM 40.0M
  • IPO Year
  • LEE N/A
  • ITRM 2018
  • Fundamental
  • Price
  • LEE N/A
  • ITRM $0.76
  • Analyst Decision
  • LEE
  • ITRM Strong Buy
  • Analyst Count
  • LEE 0
  • ITRM 1
  • Target Price
  • LEE N/A
  • ITRM $9.00
  • AVG Volume (30 Days)
  • LEE 54.9K
  • ITRM 770.5K
  • Earning Date
  • LEE 08-07-2025
  • ITRM 11-13-2025
  • Dividend Yield
  • LEE N/A
  • ITRM N/A
  • EPS Growth
  • LEE N/A
  • ITRM N/A
  • EPS
  • LEE N/A
  • ITRM N/A
  • Revenue
  • LEE $581,809,000.00
  • ITRM N/A
  • Revenue This Year
  • LEE N/A
  • ITRM N/A
  • Revenue Next Year
  • LEE N/A
  • ITRM $482.25
  • P/E Ratio
  • LEE N/A
  • ITRM N/A
  • Revenue Growth
  • LEE N/A
  • ITRM N/A
  • 52 Week Low
  • LEE $3.79
  • ITRM $0.61
  • 52 Week High
  • LEE $19.63
  • ITRM $3.02
  • Technical
  • Relative Strength Index (RSI)
  • LEE N/A
  • ITRM 57.69
  • Support Level
  • LEE N/A
  • ITRM $0.66
  • Resistance Level
  • LEE N/A
  • ITRM $0.83
  • Average True Range (ATR)
  • LEE 0.00
  • ITRM 0.05
  • MACD
  • LEE 0.00
  • ITRM 0.01
  • Stochastic Oscillator
  • LEE 0.00
  • ITRM 59.18

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: